# About Auroa Peptides — An Independent Skin Research Digest

> About Auroa Peptides: an independent literature digest on GHK-Cu and the GLOW research blend. How it is compiled, and what it is not — not a seller, not a clinic, not medical advice.

An independent, citation-grounded digest of the skin and aesthetics peptide literature. Not a vendor. Not a clinic. Not medical advice.

## What Auroa Peptides is

Auroa Peptides is an independent editorial reference desk covering the published research on two entries in the **Skin & Aesthetics** space: GHK-Cu (copper tripeptide-1) and the GLOW multi-peptide research blend. The site exists to make a scattered and frequently overstated literature legible — to tell a reader, in measured language and with citations, what each compound was actually studied for, in which models, and how far that evidence reaches.

The organizing framework is the question at the center of skin research: how does the body rebuild and maintain its matrix — the collagen and elastin scaffolding that gives skin its structure, elasticity, and tone? GHK-Cu is the most thoroughly studied answer to that question from the peptide world. GLOW is a more recent combination that builds on GHK-Cu by adding vascular and cell-migration signals, at the cost of a more complicated regulatory picture and the absence of any blend-level human trial. Reading both together gives a fuller view than either alone. Each entry has its own page, and a comparison page lines them up side by side.

## How it is compiled

Three principles govern what appears here.

*First, everything is anchored to the peer-reviewed literature.* Every research claim is tied to a numbered citation — PubMed-indexed journal articles and reviews, with DOIs and PubMed or PMC links — collected on the [references page](/references). Where a finding comes from a review rather than a primary study, the review is cited as such.

*Second, evidence is reported at its actual strength.* Doses and results are described in the species and model in which they were studied — for example, *stimulation began at 10 picomolar in human fibroblast cultures* — never scaled to people or offered as a recommendation. Where evidence is preclinical, derived from a cosmetic trial rather than a therapeutic one, or based on a parent molecule rather than the marketed blend, the page says so. That candor about limits is the core function of the desk.

*Third, the two entries cross-reference each other.* Because GHK-Cu is one of GLOW's three constituents, the pages share citations and link to one another, so a reader can follow the matrix-synthesis mechanism from one entry into the blend context.

## What it is not

Auroa Peptides is not a store, not a clinic, and not a source of medical or cosmetic advice. It does not sell, supply, source, or broker any peptide, research chemical, or cosmetic product. It has no affiliate or referral relationship with any vendor or clinic. It does not employ clinicians, diagnose conditions, or prescribe anything. It does not recommend a dose, schedule, or route of administration for any person.

The entries discussed here range from a legal cosmetic ingredient (topical GHK-Cu) to an unapproved multi-peptide blend with WADA-prohibited constituents (GLOW). Readers interested in any finding described in the underlying research should consult a licensed clinician operating within their own jurisdiction, working with regulated options appropriate to their situation. The value this site offers is a calm, accurate reading of the published literature — nothing more, and nothing it pretends to be.

---

A measured digest of peer-reviewed skin and aesthetics peptide research — citations in hand, no products on offer.